|
| 和元生物(688238)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-03-24 | 17440.26 | 26.87% | 64114.57 | 789.10 | 46674.31 | 71.91% | 首发原股东限售股份 | | 2024-03-22 | 520.00 | 0.80% | 46674.31 | 18069.00 | 35535.18 | 54.89% | 首发战略配售股份 | | 2023-12-11 | 2234.70 | 3.45% | 46154.31 | 18589.00 | 43919.61 | 67.84% | 首发原股东限售股份 | | 2023-11-27 | 697.97 | 1.08% | 43919.61 | 20823.70 | 43221.64 | 66.76% | 首发原股东限售股份 | | 2023-10-30 | 50.70 | 0.08% | 43221.64 | 21521.67 | 35535.18 | 54.89% | 首发原股东限售股份 | | 2023-09-25 | 7635.76 | 11.79% | 43170.94 | 21572.37 | 35535.18 | 54.89% | 首发原股东限售股份 | | 2023-07-03 | 2420.08 | 3.77% | 35535.18 | 28579.39 | 29063.16 | 45.33% | 首发原股东限售股份 | | 2023-06-30 | 4051.94 | 6.32% | 33633.70 | 30480.87 | 33633.70 | 52.46% | 首发原股东限售股份 | | 2023-03-22 | 15087.78 | 30.59% | 22356.28 | 26962.62 | 7309.10 | 14.82% | 首发原股东限售股份,首发战略配售股份 | | 2022-09-22 | 367.70 | 0.75% | 7309.10 | 42009.80 | 7309.10 | 14.82% | 首发机构配售股份 | | 2022-03-22 | 6900.80 | 13.99% | 6900.80 | 42418.10 | 6900.80 | 13.99% | 首发一般股份 |
|